250 related articles for article (PubMed ID: 15665104)
21. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
22. Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice.
Oyama T; Yamada Y; Hata K; Tomita H; Hirata A; Sheng H; Hara A; Aoki H; Kunisada T; Yamashita S; Mori H
Carcinogenesis; 2008 Mar; 29(3):666-72. PubMed ID: 18204079
[TBL] [Abstract][Full Text] [Related]
23. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
24. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
25. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
[TBL] [Abstract][Full Text] [Related]
26. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
27. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Verma UN; Surabhi RM; Schmaltieg A; Becerra C; Gaynor RB
Clin Cancer Res; 2003 Apr; 9(4):1291-300. PubMed ID: 12684397
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
[TBL] [Abstract][Full Text] [Related]
31. Nuclear export of alpha-catenin: overlap between nuclear export signal sequences and the beta-catenin binding site.
Giannini A; Mazor M; Orme M; Vivanco M; Waxman J; Kypta R
Exp Cell Res; 2004 Apr; 295(1):150-60. PubMed ID: 15051498
[TBL] [Abstract][Full Text] [Related]
32. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.
Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC
J Clin Invest; 2000 Aug; 106(4):533-9. PubMed ID: 10953028
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
34. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
Liu J; Wang H; Zuo Y; Farmer SR
Mol Cell Biol; 2006 Aug; 26(15):5827-37. PubMed ID: 16847334
[TBL] [Abstract][Full Text] [Related]
35. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
[TBL] [Abstract][Full Text] [Related]
36. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
Mann B; Gelos M; Siedow A; Hanski ML; Gratchev A; Ilyas M; Bodmer WF; Moyer MP; Riecken EO; Buhr HJ; Hanski C
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1603-8. PubMed ID: 9990071
[TBL] [Abstract][Full Text] [Related]
37. PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells.
Ren X; Zheng D; Guo F; Liu J; Zhang B; Li H; Tian W
Med Oncol; 2015 Apr; 32(4):91. PubMed ID: 25720524
[TBL] [Abstract][Full Text] [Related]
38. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics.
Dihlmann S; von Knebel Doeberitz M
Int J Cancer; 2005 Feb; 113(4):515-24. PubMed ID: 15472907
[TBL] [Abstract][Full Text] [Related]
39. Colon epithelial cell differentiation is inhibited by constitutive c-myb expression or mutant APC plus activated RAS.
Ramsay RG; Ciznadija D; Sicurella C; Reyes N; Mitchelhill K; Darcy PK; D'Abaco G; Mantamadiotis T
DNA Cell Biol; 2005 Jan; 24(1):21-9. PubMed ID: 15684716
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
